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Reducing Dietary Sodium
The Case for Caution
Michael H. Alderman, MD
A
UTHORITATIVE RECOMMENDATIONS,SOMETIMES SANC-
tioned by government, routinely call for reduced
dietarysodium.However,whenthestrengthofevi-
dence is made explicit, it is generally acknowl-
edged to be opinion or common “practice.”1 Advocates con-
tend that the recommendation is justified because sodium
restrictionhasbeenconvincinglyproventolowerbloodpres-
sure and that this will surely prevent stroke and myocardial
infarction. Skeptics argue that modification of this single
surrogate end point does not guarantee a health benefit as
measured by morbidity or mortality. Instead, they note that
salt restriction capable of reducing blood pressure also un-
favorably affects other cardiovascular disease surrogates.
Diet is a complicated factor involving a multitude of in-
terrelatingnutrients.Genetic,behavioral,andenvironmen-
tal factors determine wide interindividual variation in so-
dium intake compatible with good health. Thus, skeptics
of the benefits of limiting dietary sodium argue that a rec-
ommendation to reduce sodium intake should be based on
soliddirectevidencethatuniversalsaltreductionwilllower
morbidityandmortality,besafe,andpreventotherwisedire
consequences. The purpose of this Commentary is to dis-
cuss the available evidence most relevant to a recommen-
dation for universal reduction of dietary sodium.
Surrogate End Points
Surrogatemarkers,suchasbloodpressure,arenotclinicalevents,
butusuallyareassociatedwiththeincidenceofsubsequentstroke,
myocardialinfarction,kidneydysfunction,orheartfailure.Mul-
tiple randomized clinical trials (RCTs) have established that
reductionofsodiumintakesufficienttolowerbloodpressure
alsoincreasessympatheticnerveactivity,decreasesinsulinsen-
sitivity,activatesthereninangiotensinsystem,andstimulates
aldosteronesecretion.2,3Thehealtheffectsofsodiumreduction
will be the net of these conflicting effects.
Randomized Clinical Trials
RCTswithmorbidityandmortalityendpointsarethestandard
with which health and medical interventions are tested. The
onlysuchRCTsthathavecompareddifferentsodiumintakes
involvepatientswithheartfailure.4Randomizationtoamore
restricted sodium intake (1840 mg/d; to convert from mg to
mmol,divideby23)significantlyincreasedmortalityandhos-
pitalizationcomparedwiththoserandomizedtosodiumintake
of 2760 mg/d (US mean, 2921 mg/d5). These results are con-
sistent with the view that overzealous restriction of sodium
maybeharmfulforpatientswithheartfailure.6Thesetrials,al-
thoughapplicabletoheartfailurepatients,lackpublichealth
relevance.However,thosestudiesaddtothe3-yearexperience
ofTrialsofHypertensionPrevention(TOHP)inwhichseveral
thousand participants achieved long-term adherence to a
reducedsodiumregimen,andthusincreaseconfidenceinthe
feasibilityofanRCTevaluatingsodiumrestrictioninpersons
at appropriate cardiovascular disease (CVD) risk.7
Observational Studies
Rarely, smoking excepted, do observational studies by re-
peated,robust,andconsistentlypositivefindingsjustifyapub-
lic health recommendation. In fact, interventions based on
observational data are often flawed. The 1980 National Di-
etary Guidelines recommended population-wide reduction
of total fat intake. In response to an unanticipated epidemic
of obesity and diabetes, to which the authors concluded the
1980 recommendations might have contributed, the 2000
committee withdrew its earlier recommendation.8 Trans-fat
consumptionandpostmenopausalhormonetherapyareother
examples of how well-meaning interventions, based on in-
sufficient science, can have hazardous consequences.
At least 13 observational cohort studies have examined
therelationshipbetweensodiumconsumptionandclinical
outcomes,andthesestudiesincludemorethan100000par-
ticipantsandmorethan800morbidandmortalevents.The
results have been conflicting3,5,7,9 (BOX). In 2 studies with
highmeandailysodiumconsumption(Finland,4600mg/d;
Japan, 5428 mg/d), the association between salt and CVD
events was positive.3 In 11 studies with mean sodium in-
takesbetween2070mg/dand3680mg/d,2detectedaposi-
tiveassociationbetweensaltandCVDevents,andeachwas
aposthocsubgroupanalysiswithfindingsnotentirelycon-
sistent with the overall study results. For instance, in the
NHANES I, the association between salt intake and CVD
was positive in the obese subset of study participants but
was inverse in the entire sample. Likewise in the morbidity
follow-up of a subset of participants in TOHP l and II, the
association between salt and CVD was positive, whereas in
the mortality follow-up of the entire population, the asso-
ciation also was positive, but not statistically significant.
In 5 of these 11 studies, there was no association be-
tweensaltintakeandclinicaloutcome.Oneofthese5stud-
ies involving follow-up of 2275 TOHP controls had the
unique advantage of estimating usual sodium intake (3634
mg/d)bycollecting4to5urinesamplesover24hoursdur-
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wasinverselyassociatedwithCVDevents.Thus,highersalt
intake was adversely associated with CVD risk in societies
with high salt intake, whereas lower salt intake was asso-
ciated with worse outcomes in some societies with moder-
ate salt intake. A J-shaped curve, in which the most favor-
able dietary sodium range surrounds 3450 mg/d—with
possibleriskaboveandbelowthislevel—isahypothesisthat
may best accommodate the available data.3
Inarecentmeta-analysisincludingmanyofthesameob-
servational studies,10 but without stratification to account
forthesharpdifferencesinambientsodiumintakes,theau-
thors detected a significant positive association of sodium
intake with stroke. This finding was driven by studies in-
volving populations with high salt intake. However, there
wasnoassociationbetweensaltintakeandCVDevents,and
total mortality was not reported.
Notsurprisingly,givendifferentpopulations,differentdiets
and sodium intakes, different methods and conflicting re-
sults,morethan1explanatoryhypothesishasemerged.Nei-
thermoreobservationalstudiesnorfurtherdebateoverthe
available studies is likely to resolve this public health con-
troversy.
The key point, however, is not which hypothesis best fits
the observed data. The real issue relates to the inherent limi-
tations of observational studies. These investigations de-
scribethecoursepersonswhofollowachosendietmighthave
but provide no information about what might happen if that
diet were altered. That requires a randomized clinical trial.
Conclusions
Thereareatleast2pathsforward.Therashrouteisthrough
universal sodium reduction. For countries like the United
States, this means changing the diet of all its residents by
reducingthesodiumcontentofpreparedfoods.Despitethe
heterogeneity of blood pressure response to sodium reduc-
tion,advocatesofthisstrategyareconfidentthatknownben-
eficialeffectswilloutweighknownnegativeeffectsandthat
there will be no serious unintended consequences. An al-
ternate, more cautious approach, calls for rigorous, large-
scale,population-basedrandomizedclinicaltrials.Thesetrials
will likely demand a commitment by thousands of indi-
viduals for several years but will result in greater precision
and scientific credibility to help answer the question—and
vastly smaller risk of human and material resources. In the
absence of definitive evidence, both the rash and cautious
paths are experimental. Based on what is known, the pru-
dent course of action may well be caution.
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Box. Observational Studies Linking Dietary
Sodium to Cardiovascular Disease Outcomesa
Lower Salt Intake Associated With Cardiovascular Events
Worksite Hypertension Study, 1995
National Health and Nutrition Examination Survey
I, 1998
II, 2006
III, 20085
SaltIntakeHadNoAssociationWithCardiovascularEvents
Honolulu Heart Study, 1997
Scottish Heart Health Study, 1997
Health Professional Study follow-up, 1997
Multiple Risk Factor Intervention Trial, 2000
Trials of Hypertension Prevention7
1 and 2 follow-up mortality, 2007
Controls, 20099
IncreasedSaltIntakeAssociatedWithCardiovascularEvents
NationalHealthandNutritionExaminationSurvey,involv-
ing obese patients, 2000
Finnish Heart Study, 2001
Takayama, 2005
Trials of Hypertension Prevention 1 and 2, follow-up mor-
bidity, 20077
aUnless otherwise indicated, all studies listed herein are refer-
enced in Alderman.3
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